Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

335.20p
   
  • Change Today:
      4.40p
  • 52 Week High: 410.90p
  • 52 Week Low: 320.90p
  • Currency: UK Pounds
  • Shares Issued: 8,797m
  • Volume: 4,839,014
  • Market Cap: £29,486m

Haleon Overview

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate.

Key Personnel

CEO: Brian McNamara
CFO: Dawn Allen
Chairman: Manvinder Singh (Vindi) Banga
Independent Non-Executive Director: Marie-Anne Aymerich
Independent Non-Executive Director: Tracy Jayne Clarke
Independent Non-Executive Director: Dame Vivienne Cox
Independent Non-Executive Director: Asmita Dubey
Independent Non-Executive Director: Nancy Avila
Independent Non-Executive Director: Blathnaid Bergin
Independent Non-Executive Director: Matt Shattock
Senior Independent Director: Alan Stewart
Non-Executive Dir:

Contact Details

Address: Building 5, First Floor, The Heights, Weybridge, Surrey, United Kingdom, KT13 0NY
Phone: +44 (0) 371 384 2227
Website: https://www.haleon.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
ISIN: GB00BMX86B70

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Haleon Market Data

Currency UK Pounds
Share Price 335.20p
Change Today 4.40p
% Change 1.33 %
52 Week High 410.90p
52 Week Low 320.90p
Volume 4,839,014
Shares Issued 8,797m
Market Cap £29,486m

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.51% below the market average65.51% below the market average65.51% below the market average65.51% below the market average65.51% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average
Price Trend
36.69% above the market average36.69% above the market average36.69% above the market average36.69% above the market average36.69% above the market average
25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average
Income Not Available
Growth
3.94% above the market average3.94% above the market average3.94% above the market average3.94% above the market average3.94% above the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Haleon Dividends

  Latest Previous
  Interim Final
Ex-Div 13-Aug-26 09-Apr-26
Paid 17-Sep-26 14-May-26
Amount 2.40p 4.90p

Trades for 06-Oct-2026

Time Volume / Share Price
11:20 15 @ 335.20p
11:20 1,864 @ 335.20p
11:20 341 @ 335.20p
11:20 2,263 @ 335.20p
11:20 4,210 @ 335.24p

Haleon Key Personnel

CEO Brian McNamara
Chair Manvinder Singh (Vindi) Banga
CFO Dawn Allen

Top of Page